Skip to main content
. 2016 Jun 14;7(28):44236–44251. doi: 10.18632/oncotarget.10005

Figure 2. TERF2 is a marker of poor prognosis that is independent of the tumor size. A–C. Univariate survival analysis investigating the impact of the tumor size (T status), the nodal status (N status) or TERF2 expression on overall survival of patients with OSCC. D. Odds ratio for tumor size and TERF2 expression.

Figure 2